Testing the Efficacy of a Scalable Telephone-Delivered Guided Imagery Tobacco Cessation Treatment: Protocol for a Randomized Clinical Trial
Name:
resprot-2023-1-e48898.pdf
Size:
265.7Kb
Format:
PDF
Description:
Final Published Version
Affiliation
College of Nursing, University of Arizona,Department of Family and Community Medicine, University of Arizona
Mel and Enid Zuckerman College of Public Health, University of Arizona
Issue Date
2023-05-10Keywords
behavior changeguided imagery
integrative health
mobile phone
smoking
telephone
tobacco
treatment
Metadata
Show full item recordPublisher
JMIR Publications Inc.Citation
Gordon J, Armin J, Giacobbi Jr P, Hsu C, Marano K, Sheffer C. Testing the Efficacy of a Scalable Telephone-Delivered Guided Imagery Tobacco Cessation Treatment: Protocol for a Randomized Clinical Trial. JMIR Res Protoc 2023;12:e48898Journal
JMIR Research ProtocolsRights
© Judith S Gordon, Julie S Armin, Peter Giacobbi Jr, Chiu-Hsieh Hsu, Kari Marano, Christine E Sheffer. Originally published in JMIR Research Protocols. This is an open-access article distributed under the terms of the Creative Commons Attribution License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background: Tobacco use continues to be a leading preventable cause of death and disease in the United States, accounting for >480,000 deaths each year. Although treatments for tobacco use are effective for many, there is substantial variability in outcomes, and these approaches are not effective for all individuals seeking to quit smoking cigarettes. New, effective therapeutic approaches are needed to meet the preferences of people who want to stop smoking. Guided imagery (GI) is a mind-body technique that involves the guided visualization of specific mental images, which is enhanced with other sensory modalities and emotions. Preliminary evidence provides initial support for the use of GI as a treatment for cigarette smoking. Meta-analyses have shown that standard treatment for cigarette smoking delivered over the telephone via quitlines is effective. A telephone-based intervention that uses GI might provide another effective treatment option and increase the reach and effectiveness of quitlines. Objective: This study aims to test the efficacy of Be Smoke Free, a telephone-delivered GI treatment for smoking cessation. Methods: This multisite randomized clinical trial (RCT) will compare a novel telephone-delivered GI tobacco cessation treatment with a standard evidence-based behavioral treatment. The study will be conducted over 5 years. In phase 1, we refined protocols and procedures for the New York State and West Virginia sites for use in the RCT. During phase 2, we will conduct an RCT with 1200 participants: 600 (50%) recruited via quitlines and 600 (50%) recruited via population-based methods. Participants will be randomly assigned to either the GI condition or the behavioral condition; both treatments will be delivered by trained study coaches located at the University of Arizona. Assessments will be conducted at baseline and 3 and 6 months after enrollment by University of Arizona research staff. The primary outcome will be self-reported 30-day point prevalence abstinence 6 months after enrollment. Secondary outcomes include biochemically verified 7-day point prevalence abstinence 6 months after enrollment. Results: Recruitment in West Virginia and New York began in October 2022. As of March 31, 2023, a total of 242 participants had been enrolled. Follow-up assessments began in November 2022. As of March 31, 2023, of the 118 eligible participants, 97 (82.2%) had completed the 3-month assessment, and 93% (26/28) of eligible participants had completed the 6-month assessment. Biochemical verification and qualitative interviews began in April 2023. Recruitment will continue through 2025 and follow-up assessments through 2026. Primary results are expected to be published in 2027. Conclusions: The Be Smoke Free study is a first-of-its-kind RCT that incorporates GI into telephone-based tobacco cessation treatment. If successful, Be Smoke Free will have substantial benefits for the long-term health of people who use tobacco across the United States. ©Judith S Gordon, Julie S Armin, Peter Giacobbi Jr, Chiu-Hsieh Hsu, Kari Marano, Christine E Sheffer.Note
Open access journalISSN
1929-0748DOI
10.2196/48898Version
Final Published versionae974a485f413a2113503eed53cd6c53
10.2196/48898
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © Judith S Gordon, Julie S Armin, Peter Giacobbi Jr, Chiu-Hsieh Hsu, Kari Marano, Christine E Sheffer. Originally published in JMIR Research Protocols. This is an open-access article distributed under the terms of the Creative Commons Attribution License.